Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In clinical studies, participants taking semaglutide GLP-1 lost more weight on average than those taking liraglutide or other GLP-1 medications
By month 4, over 85% of patients report minimal to no side effects
Researchers who started without seeing early results often find that weeks 13 to 20 bring the acceleration they were waiting for
The same study showed that patients taking higher doses and remaining adherent achieved weight loss comparable to clinical trials
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for chronic weight management in adults with obesity or overweight with weight-related comorbidities
The formulation includes microcrystalline cellulose, magnesium stearate, and colloidal silicon dioxide as excipients to ensure stability and uniformity
US$ 20.27
US$ 22.65
US$ 27.91
US$ 28.12
US$ 24.16
US$ 29.93
US$ 27.00
US$ 28.62
